Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

951
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
951
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Glaucoma: Overview01:25

Glaucoma: Overview

1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

457
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
457
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

452
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
452

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Musculoskeletal tuberculosis presenting as polyarthritis: a diagnostic challenge.

ARP rheumatology·2026
Same author

Relapsing polychondritis in a patient treated with Dupilumab.

ARP rheumatology·2026
Same author

Updated structured report for dynamic ultrasonography in patients with suspected or known endometriosis: Recommendations of the international society for gynecologic endoscopy (ISGE).

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

Annals of the rheumatic diseases·2026
Same author

Diagnostic Performance of the Cancer Ratio in Malignant Pleural Effusion in Combination with the Light's Criteria.

Acta medica portuguesa·2026
Same author

Comparison of commercial 1Tx32Rx vs. 8Tx32Rx head coils for routine 7T neuroimaging.

Frontiers in neuroimaging·2026

相关实验视频

Updated: Jan 13, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.6K

快速诊所和巨细胞关节炎的视觉结果:系统性审查和元分析.

Tiago M B D M Beirão1, Catarina Rua1, Catarina Silva1

  • 1Rheumatology Department, Unidade Local de Saúde Gaia e Espinho, Porto, Portugal.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
|January 12, 2026
PubMed
概括

与传统实践相比,快速诊所 (FTC) 显著减少了巨细胞动脉炎 (GCA) 患者的永久视力损失和视觉障碍. 这种方法有望改善GCA患者的治疗结果.

关键词:
诊断延迟是因为诊断延迟.快速通道诊所快速通道诊所巨细胞动脉炎的发生这是一个元分析.视觉上的结果.

更多相关视频

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
07:23

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

8.7K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.5K

相关实验视频

Last Updated: Jan 13, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.6K
Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
07:23

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

8.7K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.5K

科学领域:

  • 类风湿病学 类风湿病学
  • 眼科医生 眼科 眼科
  • 临床医学 临床医学

背景情况:

  • 巨细胞动脉炎 (GCA) 是一种严重的炎症状况,影响大动脉,主要影响50岁以上的人.
  • 延迟诊断GCA可能会导致严重的并发症,包括不可逆转的视力丧失.
  • 传统的诊断方法可能会导致显著的延迟,影响患者的治疗结果.

研究的目的:

  • 为了比较快速通道诊所 (FTC) 与常规实践 (CP) 在管理GCA方面的有效性.
  • 评估FTC对GCA患者视觉结果和诊断时间表的影响.

主要方法:

  • 一个系统的审查和元分析,遵循PRISMA指南.
  • 包括的研究比较了GCA的FTC和CP,报告了视力障碍,视力丧失,活检率和诊断时间等结果.
  • 统计分析涉及汇总的几率比率 (OR) 与95%的置信区间 (CI) 和随机效应建模.

主要成果:

  • FTC与明显减少永久视力丧失 (OR:0.31;p<0.001) 和视力障碍 (OR:0.58;p=0.04) 相关.
  • 在FTC组中,动脉活检率较低 (OR:0.19;p=0.49).
  • 使用FTC,诊断的中位时间略有减少,但没有统计学意义 (OR:0.96;p=0.83).

结论:

  • 快速诊所显示了改善GCA患者视觉结果的潜力.
  • 联邦贸易委员会代表了GCA管理的一个有希望的策略,需要进一步的前性验证.